Tivic Health Systems Inc (US: TIVC) — Healthcare · Share Price, Chart & Market Data
About: Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was incorporated in 2016 and is based in Fremont, California.
Sector: Healthcare
Industry: Medical Devices
Latest price: $1.33 (+18.75%)
TIVCTivic Health Systems Inc
Loading watchlist status…
Trade TIVC now
Tivic Health Systems Inc share price
TIVC price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 11:06 am GMT+0
TIVC price performance
14.655%
5D
43.011%
1M
-6.338%
YTD
-79.444%
1Y
TIVC price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 11:06 am GMT+0
TIVC details
TIVC Market Signals